Seer, Inc. SEER
Set alert
At close · Oct 30
After hours · Oct 30, 4:34 PM ET
- YTD
- -8.20%
- 1 year
- -24.66%
- Open
- 1.89
- Prev close
- 1.94
- Mkt cap
- 93.02M
- Vol
- 516.54K
- Avg vol
- 278.19K
- EPS
- -1.22
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.62
- High
- 1.90
- Forward P/E
- -1.46
- Beta
- 1.46
- Short ratio
- 4.35
- Inst. own
- 63.75%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 8, 2024
- 50-d avg
- 2.23
- 200-d avg
- 1.93
- 1y target
- 3.00
2Y chart
Events in this range
- Nov 6, 2024Earnings: -0.34; estimate -0.29; surprise -17.24%
Signals (96)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 30, 2026 | 1 day ago |
| RSI: Oversold | Oct 30, 2026 | 1 day ago |
| MACD: Sell Signal | Oct 14, 2026 | 2 weeks ago |
| RSI: Overbought | Oct 2, 2026 | 4 weeks ago |
| RSI: Overbought | Sep 30, 2026 | 1 month ago |
| SMA: Bullish | Sep 28, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 28, 2026 | 1 month ago |
| SMA: Bullish | Sep 25, 2026 | 1 month ago |
| RSI: Oversold | Sep 23, 2026 | 1 month ago |
| SMA: Bearish | Sep 18, 2026 | 1 month ago |
| SMA: Bearish | Aug 27, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 7, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 3, 2026 | 2 months ago |
| MACD: Sell Signal | Jul 22, 2026 | 3 months ago |
| RSI: Overbought | Jul 17, 2026 | 3 months ago |
| SMA: Bullish | Jul 6, 2026 | 3 months ago |
| SMA: Bullish | Jul 6, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 6, 2026 | 3 months ago |
| RSI: Overbought | Jul 6, 2026 | 3 months ago |
| MACD: Sell Signal | Jun 9, 2026 | 4 months ago |
| SMA: Bearish | Jun 5, 2026 | 4 months ago |
| MACD: Buy Signal | May 27, 2026 | 5 months ago |
| SMA: Bullish | May 26, 2026 | 5 months ago |
| SMA: Bearish | May 12, 2026 | 5 months ago |
| MACD: Sell Signal | May 5, 2026 | 5 months ago |
| SMA: Bearish | May 4, 2026 | 6 months ago |
| SMA: Bullish | May 1, 2026 | 6 months ago |
| MACD: Buy Signal | May 1, 2026 | 6 months ago |
| MACD: Sell Signal | Apr 29, 2026 | 6 months ago |
| SMA: Bearish | Apr 22, 2026 | 6 months ago |
| SMA: Bullish | Apr 16, 2026 | 6 months ago |
| RSI: Overbought | Apr 16, 2026 | 6 months ago |
| SMA: Bullish | Apr 13, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 2, 2026 | 7 months ago |
| SMA: Bearish | Feb 27, 2026 | 8 months ago |
| SMA: Bearish | Feb 27, 2026 | 8 months ago |
| MACD: Sell Signal | Feb 27, 2026 | 8 months ago |
| SMA: Bullish | Feb 23, 2026 | 8 months ago |
| SMA: Bearish | Feb 20, 2026 | 8 months ago |
| SMA: Bullish | Feb 19, 2026 | 8 months ago |
| SMA: Bearish | Feb 18, 2026 | 8 months ago |
| SMA: Bullish | Feb 17, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 12, 2026 | 8 months ago |
| SMA: Bullish | Feb 11, 2026 | 8 months ago |
| MACD: Sell Signal | Jan 29, 2026 | 9 months ago |
| SMA: Bearish | Jan 28, 2026 | 9 months ago |
| SMA: Bullish | Jan 22, 2026 | 9 months ago |
| SMA: Bearish | Jan 13, 2026 | 9 months ago |
| SMA: Bullish | Jan 9, 2026 | 9 months ago |
| MACD: Buy Signal | Dec 16, 2025 | 10 months ago |
| RSI: Oversold | Dec 9, 2025 | 10 months ago |
| SMA: Bearish | Nov 7, 2025 | 11 months ago |
| MACD: Sell Signal | Oct 31, 2025 | 1 year ago |
| MACD: Buy Signal | Oct 27, 2025 | 1 year ago |
| MACD: Sell Signal | Oct 13, 2025 | 1 year ago |
| SMA: Bullish | Sep 18, 2025 | 1 year ago |
| SMA: Bullish | Sep 18, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 10, 2025 | 1 year ago |
| SMA: Bearish | Aug 14, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 14, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 11, 2025 | 1 year ago |
| SMA: Bullish | Aug 8, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 31, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 25, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 14, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 30, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 13, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 3, 2025 | 1 year ago |
| SMA: Bullish | Jun 2, 2025 | 1 year ago |
| SMA: Bearish | May 29, 2025 | 1 year ago |
| MACD: Sell Signal | May 28, 2025 | 1 year ago |
| MACD: Buy Signal | May 14, 2025 | 1 year ago |
| SMA: Bearish | May 6, 2025 | 1 year ago |
| MACD: Sell Signal | May 6, 2025 | 1 year ago |
| SMA: Bullish | Apr 30, 2025 | 1 year ago |
| SMA: Bearish | Apr 24, 2025 | 1 year ago |
| SMA: Bullish | Apr 22, 2025 | 1 year ago |
| SMA: Bearish | Apr 16, 2025 | 1 year ago |
| SMA: Bullish | Apr 14, 2025 | 1 year ago |
| SMA: Bearish | Apr 11, 2025 | 1 year ago |
| SMA: Bullish | Apr 10, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 7, 2025 | 1 year ago |
| RSI: Oversold | Mar 20, 2025 | 1 year ago |
| RSI: Oversold | Mar 18, 2025 | 1 year ago |
| RSI: Oversold | Mar 6, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 21, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 19, 2025 | 1 year ago |
| SMA: Bearish | Feb 3, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 3, 2025 | 1 year ago |
| SMA: Bullish | Jan 31, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 31, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 29, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 23, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 13, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 7, 2025 | 1 year ago |
| RSI: Overbought | Dec 10, 2024 | 1 year ago |
Key statistics
- Market cap
- 132.67M
- Enterprise value
- -84.89M
- Trailing P/E
- 0.00
- Forward P/E
- -1.46
- PEG ratio
- 0.00
- Price / sales
- 9.08
- Price / book
- 0.39
- EPS (TTM)
- -1.30
- Beta
- 1.46
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 14.61M
- Revenue growth
- -3.10%
- Free cash flow
- -31.91M
- Total cash
- 247.60M
- Total debt
- 26.50M
- Return on equity
- -22.03%
- Shares outstanding
- 54.92M
- Short % of float
- 2.43%
- 50-day average
- 2.23
- 200-day average
- 1.93
Analyst view
Consensus: none
- Strong buy0
- Buy1
- Hold2
- Sell0
- Strong sell0
Next earnings
Aug 8, 2024
Expected Aug 8, 2024. Consensus EPS estimate -0.37372.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 6, 2024 | Sep 1, 2024 | -0.29 | -0.34 | -0.05 | -17.24% |
| Aug 8, 2024 | Jun 1, 2024 | -0.36 | -0.35 | +0.01 | +2.78% |
| Aug 8, 2024 | Jun 1, 2024 | -0.36 | — | — | — |
| May 8, 2024 | Mar 1, 2024 | -0.31 | -0.32 | -0.01 | -3.23% |
| May 8, 2024 | Mar 1, 2024 | -0.31 | — | — | — |
| Feb 29, 2024 | Dec 1, 2023 | -0.35 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 13, 2024 | Morgan Stanley | main | Equal-Weight | Equal-Weight |
| Feb 21, 2023 | Morgan Stanley | main | — | Equal-Weight |
| Jan 4, 2023 | B of A Securities | down | Neutral | Underperform |
| Nov 10, 2022 | Morgan Stanley | main | — | Equal-Weight |
| Aug 11, 2022 | Morgan Stanley | main | — | Equal-Weight |
| Aug 11, 2022 | JP Morgan | down | Overweight | Neutral |
About Seer, Inc.
Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the biology of the proteome. It develops Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. The company intends to sell its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. It operates in China, Australia, Eastern Europe, Israel, and Japan. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- seer.bio
News
- Seer Announces Its Board Rejects Proposed Acquisition Offers From Bradley L. Radoff And Michael Torok, Omid Farokhzad; Plans To Continue As Independent Entity
- Seer to Remain an Independent Public Company Following Conclusion of Special Committee Review Process
- Genmab Announces Updated Follow-Up Analyses from Phase 2 Study of Petosemtamab Demonstrate Meaningful Objective Response Rates in Patients with Metastatic Colorectal Cancer
- Seer Q2 EPS $(0.31) Misses $(0.27) Estimate, Sales $3.100M Miss $3.550M Estimate
- Seer Affirms FY2026 Sales Guidance of $16.000M-$18.000M vs $16.250M Est
- Seer Receives Revised Acquisition Proposal From Radoff-JEC Group For $2.55 Per Share In Cash Plus A Contingent Value Right.; Special Committee To Review Both Acquisition Proposals And Other Alternatives
- Seer Receives Improved $2.55/Share Acquisition Proposal From 7.7% Stockholders Bradley L. Radoff and Michael Torok, The Radoff-JEC Group
- Seer Special Committee Unanimously Rejects Unsolicited Takeover Proposal From Chair/CEO At $2.45 Per Share In Cash Plus Two CVRs
- 12 Health Care Stocks Moving In Monday's Intraday Session
- Radoff-JEC Group Agrees With Seer CEO That It Should Not Be A Public Company; Advocates For Sale
Your note
Sign in to keep a note on SEER — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| FAROKHZAD OMID | Chief Executive Officer | Sale | Mar 6, 2024 | 1,436,280 |
| GULYANI MEETA | Director | Stock Award(Grant) | Jun 11, 2024 | 87,043 |
| HALLAL DAVID L | Director | Stock Award(Grant) | Jun 11, 2024 | 355,128 |
| HAURWITZ RACHEL E. PH.D. | Director | Stock Award(Grant) | Jun 11, 2024 | 87,615 |
| HORN DAVID R. | President | Sale | Feb 21, 2024 | 480,511 |
| KOGAN ELONA | Officer | Sale | Feb 21, 2024 | 273,142 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Softbank Group Corporation | 9.35% | 5,135,383 | 11.55M | Sep 29, 2024 |
| Siren, L.L.C. | 7.28% | 4,000,000 | 9.00M | Sep 29, 2024 |
| Blackrock Inc. | 4.79% | 2,633,090 | 5.92M | Sep 29, 2024 |
| Vanguard Group Inc | 4.27% | 2,343,345 | 5.27M | Sep 29, 2024 |
| Tang Capital Management, LLC | 4.19% | 2,300,000 | 5.17M | Sep 29, 2024 |
| Acadian Asset Management. LLC | 3.94% | 2,165,412 | 4.87M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.90% | 1,594,055 | 3.59M | Sep 29, 2024 |
| Fidelity OTC Portfolio | 1.06% | 584,245 | 1.31M | Oct 30, 2024 |
| Vanguard Extended Market Index Fund | 0.94% | 517,365 | 1.16M | Sep 29, 2024 |
| Bridgeway Funds Inc-Ultra Small Company Fund | 0.84% | 462,943 | 1.04M | Sep 29, 2024 |
| BlackRock Advantage Small Cap Core Fund | 0.59% | 322,240 | 725.04K | Aug 30, 2024 |
| Fidelity Extended Market Index Fund | 0.44% | 239,470 | 538.81K | Oct 30, 2024 |